Skip Navigation

U.S. Department of Health & Human ServicesLink to HHS.gov
OMH Home

En Español
The Office of Minority Health (Phone: 1-800-444-6472)
About OMH
Our Services
Campaigns/Initiatives
Press Releases
Calendar
Employment
Publications
Federal Clearinghouses
Research
OPHS Home

Image of a person asking a questionNeed Help?
Contact Us
National Partnership for Action to End Health Disparities


Aids.gov - Access to U.S. Government HIV and AIDS information

HIV/AIDS Awareness Days
Join Our Mailing ListJoin Our Mailing List
Click to sign up


OMH Content via HealthDay

  Last Seven Days' Health News
Clinical Trials Update: May 13, 2009

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch:

Chronic Constipation

Researchers are evaluating an investigational medication to see if it effectively treats constipation.

The research site is in Burbank, Calif.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/constipation.aspx Exit Disclaimer.

-----

Hypertension (High Blood Pressure)

This 21-week study is for people aged 18 to 79 who have been diagnosed with mild-to-moderate hypertension.

The research site is in Hollywood, Fla.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/hypertension.aspx Exit Disclaimer.

-----

Healthy Volunteers

This study, for healthy volunteers 65 and older, will evaluate an investigational medication to treat Alzheimer's disease.

The research site is in Tempe, Ariz.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/healthy_volunteers.aspx Exit Disclaimer.

-----

Schizophrenia and Schizoaffective Disorders

If you are aged 18 to 65 with schizophrenia or schizoaffective disorder, you may qualify for this study.

The research site is in Boston, Mass.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=135 Exit Disclaimer.

-----

Renal Cell Carcinoma

If you have renal cell carcinoma and have received no prior systemic therapy (interleukin-2, interferon-alpha, chemotherapy, bevacizumab, mTOR inhibitor, sunitinib, sorafenib or other VEGF TKI), you may qualify for this study.

The research site is in Beech Grove, Ind.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=363 Exit Disclaimer.

-----

Anemia

If you are an adult with iron deficiency anemia and have had an unsatisfactory response to oral iron, you may qualify for this study.

The research site is in Tulsa, Okla.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=373 Exit Disclaimer.

-----

Copyright 2009 ClincalConnection.com and CenterWatch. All rights reserved.

Copyright © 2009 ScoutNews, LLC Exit Disclaimer. All rights reserved.

HealthDayNews articles are derived from various sources and do not reflect federal policy.
omhrc.gov does not endorse opinions, products, or services that may appear in news stories.
Content Last Modified: 5/13/2009 10:11:00 AM
OMH Home  |  HHS Home  |  USA.gov  |  Disclaimer  |  Privacy Policy  |  HHS FOIA  |  Accessibility  |  Site Map  |  Contact Us  |  File Formats

Office of Minority Health
Toll Free: 1-800-444-6472 / Fax: 301-251-2160
Email: info@omhrc.gov

Provide Feedback